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Abstract
3P-Ends of almost all eukaryotic mRNAs are generated by endonucleolytic cleavage and addition of a poly(A) tail. In
mammalian cells, the reaction depends on the sequence AAUAAA upstream of the cleavage site, a degenerate GU-rich
sequence element downstream of the cleavage site and stimulatory sequences upstream of AAUAAA. Six factors have been
identified that carry out the two reactions. With a single exception, they have been purified to homogeneity and cDNAs for 11
subunits have been cloned. Some of the cooperative RNA-protein and protein-protein interactions within the processing
complex have been analyzed, but many details, including the identity of the endonuclease, remain unknown. Several examples
of regulated polyadenylation are being analyzed at the molecular level. In the yeast Saccharomyces cerevisiae, sequences
directing cleavage and polyadenylation are more degenerate than in metazoans, and a downstream element has not been
identified. The list of processing factors may be complete now with approximately a dozen polypeptides, but their functions in
the reaction are largely unknown. 3P-Processing is known to be coupled to transcription. This connection is thought to involve
interactions of processing factors with the mRNA cap as well as with RNA polymerase II. ß 1999 Published by Elsevier
Science B.V. All rights reserved.
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1. Introduction
Mature eukaryotic messenger RNAs are generated
from larger precursors, the primary products of
RNA polymerase II, by a series of processing steps,
all of which take place in the cell nucleus. 3P-End
processing is one of them. All pre-mRNAs in all
eukaryotic organisms ¢rst lose sequences from their
3P-ends by an endonucleolytic cleavage. Almost all
RNAs then receive a polyadenylate tail (Fig. 1).
The only known exceptions to this rule are the major
histone mRNAs in metazoan cells. While they are
also cleaved endonucleolytically, these RNAs are
not polyadenylated, and the factors responsible for
cleavage di¡er from the ones acting on all other pre-
mRNAs.
The poly(A) tails at the 3P-end of the mRNA func-
tion in the initiation of translation. A protein-medi-
ated interaction with the cap at the 5P-end of the
RNA helps to load the 40S ribosomal subunit onto
the message [1]. In addition, the poly(A) tails play a
role in the regulation of mRNA stability as dead-
enylation is frequently the ¢rst and rate-limiting
step of mRNA decay [2]. Finally, the poly(A) tail
is thought to be involved in the export of mRNA
from the nucleus into the cytoplasm [3,4].
Poly(A) tails are also found on prokaryotic
mRNAs. However, whereas polyadenylation is an
essential step in the production of functional
mRNA in eukaryotes, it appears to be a prelude to
degradation in bacteria (see elsewhere in this vol-
ume).
Progress in the understanding of mRNA 3P-end
formation has been summarized in numerous reviews
[5^12]. This overview will therefore be selective
rather than comprehensive, focusing on recent ad-
vances in the biochemical understanding of the
mechanism of cleavage and polyadenylation in mam-
malian cells and in Saccharomyces cerevisiae and on
selected regulatory aspects.
The basic 3P-end processing reaction is identical
from yeast to man. However, the RNA sequences
directing the process and the proteins catalyzing it
are su⁄ciently distinct that the two systems will be
discussed separately.
2. Cleavage and polyadenylation in mammalian cells
2.1. Cleavage and polyadenylation signals
Sequence requirements for 3P-end formation have
been reviewed [10,13] and will be treated brie£y. The
reaction depends on three sequences in the pre-
mRNA. Among these, the hexanucleotide
AAUAAA, located 10^30 nucleotides upstream of
the cleavage site, stands out by its high degree of
conservation: most mRNAs have a perfect hexanu-
cleotide; AUUAAA is the only relatively common
variant, and all other deviations from the consensus
are extremely rare. When these rare deviations are
introduced by directed mutagenesis, they essentially
inactivate a wild-type signal.
A second sequence, the so-called downstream ele-
ment, is usually located roughly within the ¢rst 30
nucleotides of the cleavage site, but can also function
further downstream [14]. Although several sequence
motifs have been proposed based on sequence com-
parisons and mutagenesis studies (reviewed in [15]), a
Fig. 1. The two steps in 3P-processing. Endonucleolytic cleavage
between the AAUAAA sequence and the downstream element
(represented by the oligo(U) stretch) generates an upstream frag-
ment terminating with 3P-OH and a downstream fragment start-
ing with 5P-phosphate. The upstream fragment is polyadenylated,
the downstream fragment is degraded. Reproduced from [9].
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convincing consensus for the downstream element
was not achieved, and the element is usually de-
scribed vaguely as ‘U-rich’ or ‘GU-rich’. The di¡use
nature of the downstream element is also re£ected in
the fact that it is relatively insensitive to point muta-
tions; sometimes extended deletions are necessary
for a complete inactivation. More recently, sequence
requirements for the downstream element have been
analyzed by RNA selection procedures with the pu-
ri¢ed protein responsible for the recognition of this
sequence. These results will be discussed below.
There is no strict requirement for the precise se-
quence at which cleavage occurs, but the phospho-
diester bond on the 3P-side of an A is preferred, and
frequently a CA dinucleotide is found at the site of
cleavage. The spacing of AAUAAA and the down-
stream element, together with such a local sequence
preference, is thought to determine the precise cleav-
age site [16].
Many viral and at least some cellular genes also
contain sequences upstream of AAUAAA that in-
crease the e⁄ciency of 3P-processing. These sequen-
ces are generally U-rich but have no obvious further
similarity. One particular type of upstream sequences
is essential for a cytoplasmic poly(A) tail extension
reaction that occurs under developmental control
during oocyte maturation and early embryogenesis
in a wide variety of metazoans [17] (earlier work
reviewed in [10,18]). These sequences, called cyto-
plasmic polyadenylation elements (CPE), are usually
located immediately upstream of the AAUAAA hex-
anucleotide and are, in contrast to other upstream
elements, well de¢ned: those active during oocyte
maturation are related to UUUUUUAU whereas
those active during early embryogenesis consist of
more extended runs of Us.
The ability of very short AAUAAA-containing
oligoribonucleotides to bind polyadenylation factors
and be polyadenylated [19] suggests that this se-
quence is recognized in a single-stranded form, and
this conclusion is supported by RNA structure pre-
diction and probing and by mutagenesis [20^22]. The
optimal conformation of the region surrounding
AAUAAA is less certain. Sequence comparisons
and mutagenesis indicate that a stem-loop structure
of low stability with the hexanucleotide in the loop
may have a moderate stimulatory e¡ect on process-
ing [20,23]. Another study concluded from selection
experiments that a larger unstructured region around
AAUAAA favors the recognition of the hexanucleo-
tide [22].
2.2. Cleavage and polyadenylation factors
Short RNAs containing the sequences discussed
above are speci¢cally cleaved and polyadenylated in
crude nuclear extracts of HeLa cells. Reconstitution
of the reactions with fractions derived from these
extracts or from calf thymus extracts has been the
basis for puri¢cation of the cleavage and polyadenyl-
ation factors.
Cleavage and polyadenylation speci¢city factor
(CPSF) can be regarded as the central player in 3P-
processing. CPSF binds directly to the cleavage and
polyadenylation signal AAUAAA and, like this se-
quence, is required for both partial reactions. The
protein contains four subunits, apparently one copy
of each. Subunit association is tight as demonstrated
by co-puri¢cation and co-precipitation with antibod-
ies [24^27]. The largest polypeptide, with a molecular
mass of 160 kDa (CPSF-160), can be cross-linked to
AAUAAA by UV irradiation [26,28], and the re-
combinant subunit on its own binds this sequence,
albeit with limited speci¢city [29]. A possible similar-
ity of a part of the protein to a well-characterized
RNA binding domain, the so-called RNP domain
(reviewed by [30,31]), has not yet been tested exper-
imentally [29]. The smallest subunit of CPSF (30
kDa) can also be cross-linked to the polyadenylation
hexanucleotide [26,28]. The protein contains ¢ve zinc
¢ngers and one zinc knuckle and binds RNA as an
isolated polypeptide [27]. CPSF-30 prefers poly(U)
among the homopolymers, but SELEX experiments
[32] did not de¢ne a speci¢c binding site [33]. RNA
binding is partially dependent on the zinc knuckle
motif. The 30-kDa subunit has been undetectable
in stained SDS gels in two published CPSF prepara-
tions, suggesting that the polypeptide is held in the
complex less tightly and may not be essential for
CPSF function [25,34]. A requirement for mamma-
lian CPSF-30 has not been rigorously tested. Studies
on the Drosophila homologue of CPSF-30, clipper,
have revealed a developmental regulation of its ex-
pression. Speci¢cally, the protein was not detectable
throughout embryogenesis [33], although transcrip-
tion and, thus, RNA processing in the embryo starts
FEMSRE 648 12-5-99 Cyaan Magenta Geel Zwart
E. Wahle, U. Ru«egsegger / FEMS Microbiology Reviews 23 (1999) 277^295 279
at the cellular blastoderm stage. While the limit of
detection in these experiments was not de¢ned, the
results suggest that the protein might be dispensable
for CPSF function. In contrast, the gene encoding
the yeast protein corresponding to CPSF-30 is essen-
tial for viability (see Section 3.2). Mammalian CPSF-
30 is bound by the in£uenza virus NS1 protein. NS1
inhibits cleavage and polyadenylation by blocking
the RNA binding activity of CPSF and thus contrib-
utes to a shut-down of host gene expression [35]. The
two remaining CPSF subunits of 100 and 73 kDa
have also been cloned [36,37]. Their functions are
unknown, and their sequences have been uninforma-
tive except for the surprising fact that they are sim-
ilar to each other.
CPSF may also be involved in the recognition of
upstream sequence elements. In in vitro experiments,
puri¢ed CPSF was able to discriminate between an
RNA containing the cytoplasmic polyadenylation el-
ement mentioned above and an RNA lacking this
sequence; the former was preferentially bound and
polyadenylated [38,39]. Similar results have been ob-
tained with upstream elements of viral poly(A) sites
[34,40]. Direct binding of CPSF to the upstream el-
ement of the HIV poly(A) site was demonstrated by
a protein-RNA cross-link mapped to this region [34].
The upstream region of the HIV poly(A) site has
been randomized and functional variants promoting
binding of CPSF have been selected. They had in
common only that they were unstructured [22].
Although this is not what one would have expected
for a direct binding of CPSF to sequences upstream
of AAUAAA, a structural e¡ect does not necessarily
contradict a direct interaction either. Evidence has
also been presented that upstream elements can be
recognized by proteins distinct from CPSF: the CPE
binding protein from Xenopus oocytes [41^43] binds
cytoplasmic polyadenylation elements, and its deple-
tion from extracts inhibits CPE-dependent polyaden-
ylation. The protein has not been tested in reconsti-
tution experiments with puri¢ed polyadenylation
factors. The A protein of the U1 snRNP has been
suggested to bind the upstream element of the SV40
late polyadenylation signal [44,45]. Although the
protein was shown to stimulate polyadenylation in
a reconstituted reaction, this e¡ect was independent
of the upstream element. Recently, the polypyrimid-
ine tract binding protein (PTB) has been shown to
bind the upstream element of the C2 complement
gene, and reconstitution experiments demonstrated
a stimulation of 3P-cleavage dependent on the pres-
ence of the upstream element [46].
A second well-studied protein required for cleav-
age is the cleavage stimulation factor (CstF) [47].
CstF binds the downstream element of the polyaden-
ylation signal, and the protein, like its binding site,
is essential for cleavage but not required for poly-
adenylation. The protein has three subunits of 77, 64
and 50 kDa in a 1:1:1 ratio, all of which are essen-
tial for activity [47,48]. The 77-kDa subunit connects
the two others. The 64-kDa subunit can be cross-
linked to substrate RNAs [47], and the cross-link
has been mapped to the downstream element [49].
A clear match to the RNP domain is found in this
protein [50].
Since no consensus sequence could be deduced
from natural downstream elements (see above), SE-
LEX experiments [32] have been used to determine
which exact sequence is recognized by CstF. In one
study, SELEX experiments were carried out with the
isolated RNP domain of CstF-64 [14]. RNA mole-
cules with repeated GU dinucleotides were selected
from the random pool, in agreement with the GU-
rich nature of naturally occurring downstream ele-
ments. The RNA sequences selected bound not
only the isolated RNP domain but also intact
CstF, and they functioned as downstream elements
in cleavage assays. In an independent study, the
complete CstF heterotrimer was used for selection
[15]. In this case, three extended consensus sequences
were selected: AUGCGUUCCUCGUCC and the re-
lated sequences YGUGUYN0ÿ4UUYAYUGYGU
and UUGYUN0ÿ4AUUUACUGN0ÿ2YCU. All of
these sequences were functional downstream ele-
ments in processing assays. The basis for the discrep-
ancy between the two SELEX experiments is not
clear. It is possible that the isolated RNP domain
does not have the full sequence speci¢city of CstF
^ it certainly does not have the full a⁄nity [14]. The
results of Beyer et al. [15] may have been in£uenced
by the fact that the 64-kDa subunit of CstF is het-
erogeneous [15,47]. While the basis of the heteroge-
neity is unknown, it is unlikely to be simply an arti-
fact of proteolysis during puri¢cation. Thus, it is
conceivable that di¡erent forms of CstF di¡er in
their sequence preferences.
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The results of the selection experiments demon-
strate that the variability of the downstream element
is not due to a lack of sequence speci¢city of CstF.
Instead, the variability is probably related to the co-
operative nature of substrate recognition by the
processing complex: interactions among the protein
components of the complex (see Section 2.3) are as
important as their interactions with speci¢c RNA
sequences, so that variable RNA sequences can be
accommodated in the context of a cleavage and poly-
adenylation signal.
In addition to the RNA binding domain, the three
subunits of CstF contain other interesting sequence
motifs. These include transducin repeats in the 50-
kDa subunit [51] and tetratricopeptide repeats in the
77-kDa subunit, both of which are thought to medi-
ate protein-protein interactions (reviewed by [11]).
Their roles in complex assembly or processing are
not yet known.
CstF-77 has strong sequence similarity to the Dro-
sophila gene suppressor of forked (su(f)) [48,52]. The
phenotype of the su(f) mutations is consistent with a
role of the protein in mRNA 3P-end formation
[48,53]. Like CPSF-30, CstF-77 does not show a uni-
form expression in £y tissues [54]. CstF-77 autoregu-
lates its own synthesis by promoting the use of an
internal cleavage/polyadenylation site that leads to a
truncated mRNA [55].
Although CstF binds the downstream polyaden-
ylation element and is not essential for pre-mRNA
polyadenylation, it can also stimulate the polyaden-
ylation of the C2 complement mRNA by binding to
the upstream polyadenylation element. As discussed
above, a di¡erent factor, PTB, is thought to use the
same sequence for stimulating the ¢rst step in the 3P-
processing reaction [46].
Cleavage factor I (CF Im ; the abbreviation distin-
guishes the protein from yeast CF I (CF Iy ; see Sec-
tion 3.2), which is not related in protein structure) is
a third protein required for cleavage. Like CstF, it is
dispensable for polyadenylation. CF Im has been pu-
ri¢ed as a mixture of polypeptides of 72, 68, 59 and
25 kDa [56,57]. In vitro reconstitution from recombi-
nant polypeptides demonstrated that the 68- and 25-
kDa subunits are su⁄cient to reconstitute functional
CF Im [57]. Partial cDNA sequences and antibody
reactivity revealed that the 72- and 59-kDa polypep-
tides are related to the 68-kDa protein. Presumably,
the 25-kDa subunit can associate with any one of the
large subunits, generating di¡erent forms of CF Im.
The factor binds RNA in gel shift and ¢lter binding
experiments, and at least the 68-, 59- and 25-kDa
polypeptides can be UV cross-linked to RNA [56].
Although a preference of CF Im for binding poly-
adenylation substrates was reported, the RNA bind-
ing speci¢city of the protein remains to be investi-
gated more thoroughly. It is also a matter of
speculation whether the di¡erent forms of CF Im
have di¡erent substrate preferences. Interestingly,
the sequence of CF I-68 shows the characteristic fea-
tures of the so-called spliceosomal SR proteins: an
N-terminal RNP domain and a C-terminal domain
containing a number of serine-arginine (SR) dipep-
tides as well as arginines alternating with glutamate
or aspartate. The protein is recognized by a mono-
clonal antibody diagnostic for SR proteins. In CF I-
68, the RNP domain and the SR domain are con-
nected by an extremely proline-rich region. With the
exception of CF I-68, all known SR proteins play
essential and/or regulatory roles in pre-mRNA splic-
ing. In particular, they bind the RNA substrate and
recruit other processing factors, thus committing the
RNA to the splicing event (reviewed by [58^60]. A
possibly similar role of CF Im in 3P-end processing
will be discussed in Section 2.3.
An additional factor, cleavage factor II (CF IIm),
is also essential for cleavage [61], but it has not been
puri¢ed to homogeneity, and its function is un-
known.
Poly(A) polymerase is the enzyme catalyzing the
addition of the poly(A) tail, but it is also involved in
the cleavage reaction. In reconstituted reactions, the
enzyme appears to be essential for the cleavage of
some substrates and non-essential but stimulatory
for at least one RNA. Poly(A) polymerase is a single
monomeric polypeptide that occurs in di¡erent splice
forms [62^67]. The catalytically active forms have
molecular masses around 80 kDa. They di¡er in ami-
no acid sequences at the C-terminus, which are irrel-
evant for the catalytic function. Several forms of
approximately 43 kDa have also been found by
cDNA cloning [63,65,67]. They are catalytically in-
active (but see [65]), and, while the mRNAs are
present in cells, protein expression is below the limit
of detection. As the shortened mRNAs are generated
by the utilization of cleavage and poyladenylation
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sites within introns, they may be the product of an
autoregulatory mechanism [67]. The catalytic center
of poly(A) polymerase is related to those of other
nucleotidyl transferases [68]: from sequence align-
ments and site-directed mutagenesis it has been con-
cluded that three aspartate residues bind two diva-
lent metal ions that are directly involved in
catalyzing an in-line attack of the primer’s 3P-OH
group on the K-phosphate of the incoming ATP.
Inversion of con¢guration at the K-phosphate is con-
sistent with this mechanism [69]. A site for binding
the RNA primer is thought to overlap with the nu-
clear localization signal [68,70]. Indirect evidence
suggests that the closely related poly(A) polymerase
from yeast may bind the RNA with two distinguish-
able sites [71]. A C-terminal domain of about 20 kDa
is dispensable for the catalytic activity, but multiple
phosphorylations in this domain can regulate the
activity of the polymerase (see Section 2.4).
The minimal set of proteins directly involved in 3P-
end formation is completed by the poly(A) binding
protein II (PABP2; the original name PAB II was
revised based on human genetic nomenclature regu-
lations), which binds poly(A) and plays a role during
the elongation of poly(A) tails [72,73]. PABP2 has a
monomeric molecular mass of 33 kDa. It forms var-
ious ill-de¢ned oligomers in solution, the functional
signi¢cance of which is uncertain. The protein has an
N-terminus rich in glutamate residues, followed by
an RNP-type RNA binding domain and an arginine-
rich C-terminus [74]. PABP2 has recently received
some attention because mutations leading to oculo-
pharyngeal muscular dystrophy have been mapped
to the PABP2 gene [75]. The protein carries at its
N-terminus the sequence Met-Ala10-Gly-Ala2. Minor
extensions of the polyalanine sequence ^ a recessive
allele has only one additional alanine ^ lead to dis-
ease, most likely by causing the protein to precipitate
in the cell nucleus. It remains to be elucidated how
this damages the cells and why certain cell types are
more a¡ected than others.
The mammalian 3P-processing factors are summar-
ized in Table 1.
2.3. Complex assembly and reaction mechanism
The proteins discussed above are su⁄cient to re-
constitute 3P-cleavage and polyadenylation in vitro.
As already alluded to, CPSF, CstF, CF Im, CF IIm
and poly(A) polymerase are involved in cleavage,
whereas CPSF, poly(A) polymerase and PABP2
carry out polyadenylation. In reconstituted reactions
as well as in crude extract, the two partial reactions
are tightly coupled, i.e. cleavage is immediately fol-
lowed by polyadenylation so that a 5P-cleavage frag-
ment lacking poly(A) is not detectable. Coupling is
presumably due to the fact that poly(A) polymerase
is already involved in pre-mRNA cleavage, i.e.
present in the RNA-protein complex carrying out
this reaction and positioned to extend the newly cre-
ated 3P-end. Coupling of cleavage and polyadenyla-
tion is, however, not obligatory: selective inhibition
of polyadenylation by chain-terminating ATP ana-
logs or by a low concentration of EDTA leads to
an accumulation of the cleavage product (extended
by a single nucleotide under the former condition).
Also, in the case of the SV40 late polyadenylation
site, cleavage occurs in the absence of poly(A) po-
lymerase, albeit with reduced e⁄ciency. So-called pre-
cleaved RNAs, generated in vitro by run-o¡ tran-
scription so as to end at or near the natural cleavage
Table 1
Mammalian cleavage and polyadenylation factors
Factor Subunits
(molecular mass
in kDa)
Function
CPSF 160 cleavage and polyadenylation;
binds AAUAAA; interacts with
CstF, PAP and CF Im
100
73
30
CstF 77 cleavage; binds downstream
element; interacts with CPSF64
50
CF Im 72, 68, 59 cleavage; binds RNA; interacts
with CPSF; functional CF Im is
probably composed of one of the
three large subunits and the
25-kDa subunit
25
CF IIm unknown cleavage
PAP 82 cleavage and polyadenylation;
catalyzes AMP polymerization;
interacts with CPSF
PABP2 33 poly(A) extension; stimulates
poly(A) polymerase; essential for
length control
Reproduced from an article entitled ‘mRNA formation: 3P end’,
Encyclopedia of Life Sciences, Macmillan Reference Ltd/Grove’s
Dictionaries Inc. (forthcoming).
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site, are polyadenylated independently of the cleav-
age reaction. This cleavage-independent polyadenyl-
ation is AAUAAA-dependent. Cleavage leads to
an upstream fragment ending with a 3P-hydroxyl
and a downstream fragment with a 5P-phosphate.
As this type of endonuclease reaction is usually
catalyzed with the help of metal ions, the resist-
ance of the cleavage reaction against EDTA is un-
usual. The downstream RNA fragment generated in
the cleavage reaction is degraded unless nucleases
have been removed by puri¢cation of processing fac-
tors or inactivated by sequestration of Mg2 with
EDTA.
Early experiments in crude extracts showed that
ATP was required for the reaction not just as a sub-
strate for poly(A) polymerase but already for the
cleavage reaction and even for the assembly of the
RNA-protein complex carrying out the processing
reaction (reviewed in [5]). Hydrolysis of ATP, how-
ever, was not required. The ATP requirement has
been re-examined in a reconstituted reaction with
recombinant poly(A) polymerase and puri¢ed or
partially puri¢ed CPSF, CstF, CF Im and IIm [76].
The surprising result was that the reaction did not
require ATP but creatine phosphate. This compound
is traditionally added to replenish the ATP pool de-
pleted by ATPases in a crude extract, but a number
of controls excluded the possibility that creatine
phosphate served in this function in the reconstituted
reaction. Whereas ATP was dispensable with one
substrate RNA it was strongly stimulatory with an-
other. Hydrolysis of creatine phosphate or transfer
of its phosphate group to proteins was not detected.
Thus, creatine phosphate may have an allosteric ef-
fect. However, very high concentrations were re-
quired. Also, arginine phosphate was as e⁄cient as
creatine phosphate, and even simple inorganic phos-
phate substituted at detectable levels. Thus, as sug-
gested by the authors, the phosphorylated com-
pounds may serve as a substitute for the true
physiological e¡ector, possibly a phosphorylated
protein, that remains to be identi¢ed. A possible
candidate for this protein is discussed in Section 4.
Before cleavage takes place, a complex is formed
between most or all of the processing factors and the
substrate RNA. Initially identi¢ed in crude extracts,
the 3P-processing complex has now been partially
reconstituted with puri¢ed proteins. Although com-
plexes form rapidly, the cleavage reaction proceeds
very slowly, even in reconstituted reactions, in which
protein concentrations and reaction conditions have
been optimized (e.g. [57]). Polyadenylation of a pre-
cleaved substrate, in contrast, can be complete in a
few seconds, at least under favorable conditions in a
reconstituted reaction.
The cleavage complex is assembled in a coopera-
tive manner: while CPSF and CstF, independently of
each other, can bind the AAUAAA sequence and
the downstream element, respectively (see above),
they mutually stabilize their interaction with the
RNA [25,77,78]. An interaction of CstF-77 with
CPSF-160 has been demonstrated [29] and is pre-
sumably involved in complex assembly. The e⁄-
ciency of a cleavage/polyadenylation site has been
found to be re£ected in the stability of its interaction
with CPSF and CstF (discussed in [6]). Poly(A) po-
lymerase on its own binds RNA very weakly and
non-speci¢cally, but it stabilizes the binding of
CPSF to the RNA and thus is tethered to the
RNA by CPSF [25,79]. Again, an interaction with
CPSF-160 has been detected [29].
Based on the binding assays discussed above, the
prevailing view was that the binding of CPSF and/or
CstF are early events in the assembly of a 3P-pro-
cessing complex, followed by the recruitment of other
factors. However, when these assays were done, CF
Im and CF IIm were not available in a puri¢ed form
to be tested in binding assays. Now CF Im is avail-
able and has been demonstrated to be capable of
independent RNA binding (see above). Again, coop-
erative e¡ects exist : CF Im stabilizes an RNA-CPSF
complex in the presence or absence of CstF and
poly(A) polymerase. In contrast, CF Im does not
stabilize the interaction of CstF with RNA, and no
factor except CPSF strengthens RNA binding of CF
Im. This implies an interaction between CF Im and
CPSF [56]. (CF IIm has not been tested in this type
of assay.) Moreover, a preincubation of the substrate
RNA with CF Im has a readily detectable stimula-
tory e¡ect on the cleavage e⁄ciency, strongly sug-
gesting that CF Im should contact the RNA ¢rst
[57]. It is possible that CF Im in some manner pre-
pares the RNA for the binding of the other proteins.
For example, it has been observed that CstF prefers
to bind short RNAs compared to long RNAs, sug-
gesting that binding might be inhibited by RNA
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structure [14]. Binding of CstF is also slow (K. Bey-
er, unpublished observations, cited in [57]).
The stimulatory e¡ect of a preincubation of RNA
and CF Im is reminiscent of the e¡ects of SR pro-
teins in splicing. A puzzling aspect is the following: a
30-min preincubation is su⁄cient to increase cleav-
age e⁄ciency. However, the stimulation is due not so
much to the shortening of the lag period preceding
the cleavage reaction, but mostly to an increased
cleavage rate that is maintained over the course of
2 h. In other words, the rate of the reaction without
preincubation never catches up, even after a length
of time exceeding that of the preincubation. In this
context, it is a mystery why cleavage proceeds at
such a slow rate. Of course, as long as CF IIm has
not been puri¢ed, one cannot exclude the possibility
that its concentration limits the reaction rate. How-
ever, it is also possible that in the presence of satu-
rating amounts of all proteins some intrinsically slow
step, like a rearrangement of the complex, is limiting.
Another unsolved and important question con-
cerns the identity of the nuclease cleaving the
RNA. None of the polypeptides discussed above
has so far been proven to be responsible for this
activity. The 30-kDa subunit of CPSF has been sug-
gested to be a ribonuclease [80]. However, as dis-
cussed above, it is possible that this subunit is not
essential for CPSF activity. In addition, a yeast
strain carrying a mutation in the gene encoding the
homologous protein has a speci¢c defect in polyad-
enylation, not in 3P-cleavage [27]. These data may
have to be interpreted with caution, though, as dis-
cussed below.
A model of the cleavage complex is presented in
Fig. 2.
Assembly of the polyadenylation complex, like
that of the cleavage complex, also involves coopera-
tive interactions. Poly(A) polymerase on its own is
essentially inactive, apparently due to its weak a⁄n-
ity for RNA [81]. It can be activated in a non-phys-
iological manner by Mn2 ions and will indiscrimin-
ately polyadenylate any RNA under these
conditions. In the physiologically meaningful reac-
tion, taking place in the presence of Mg2, the en-
zyme interacts with CPSF on the RNA, as shown
both by the stimulatory e¡ect of CPSF on poly(A)
synthesis and by gel retardation assays [25,79]. Spe-
ci¢c binding of CPSF to AAUAAA-containing sub-
strates is responsible for the speci¢c polyadenylation
of these RNAs. Provided that the RNA also con-
tains an oligo(A) tail of at least 10 nucleotides,
PABP2 can join the complex and further stabilize
it, as demonstrated by measurements of complex
half-life [79]. The e¡ect of PABP2 on the polymerase
is independent of CPSF: a strong stimulation of po-
lymerase activity is observed on a simple poly(A)
primer in the absence of CPSF [72]. The tethering
of poly(A) polymerase to the RNA leads to an in-
creased processivity of elongation: whereas the en-
zyme by itself is entirely distributive, i.e. dissociates
after the incorporation of every single nucleotide,
Fig. 3. A model of the polyadenylation complex. CPSF remains
on the AAUAAA sequence whereas PABP2 binds the poly(A)
tail. The extended structure of the tail may not be real. A direct
interaction between poly(A) polymerase and PABP2 has not
been proven. Reproduced from [9].
Fig. 2. A model of the cleavage complex. Whereas some of the
interactions shown have an experimental basis (see text), others
are hypothetical. The positions of CF I, CF II and poly(A) po-
lymerase in the complex are not known. Reproduced from [9],
with modi¢cations.
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either PABP2 or CPSF make it slightly processive.
The combined activity of both stimulatory factors
leads to a fully processive elongation: A complete
poly(A) tail can be synthesized without dissociation
of the polymerase [79].
A cartoon of the polyadenylation complex is
shown in Fig. 3.
Interestingly, the processive elongation reaction
terminates when approximately 250 nucleotides
have been added. The further elongation is distrib-
utive and, therefore, slow. Thus, the reconstituted
reaction makes poly(A) tails of the same length
that is generated in vivo [82]. This length control
relies on a true measurement of poly(A) tail length,
as substrates with di¡erent lengths of pre-made
poly(A) tails always receive the correct number of
adenylate residues to result in a total length of about
250.
How the cleavage complex makes the transition to
the polyadenylation complex is unknown. As dis-
cussed previously [10], there is reason to believe
that the downstream fragment and the cleavage fac-
tors may not be released until a tail of 10 adenylate
residues has been added to the upstream RNA frag-
ment and PABP2 binds the growing tail. The ¢nal
transition of the polyadenylation complex that leads
to the termination of processive synthesis also re-
mains to be analyzed.
2.4. Regulatory aspects
Regulation of 3P-end formation has been reviewed
[10,11]. Therefore, only three selected systems will be
discussed in which signi¢cant progress has been
made recently.
As mentioned above, poly(A) polymerase has a
serine/threonine-rich C-terminal domain dispensable
for catalytic activity and for interaction with other
components of the cleavage and polyadenylation
complexes. This domain is phosphorylated in vivo
[64,66,83]. The kinase that is most likely responsible
is the cdc2/cyclin B complex, also known as mitosis
promoting factor (MPF), which is responsible for
driving the cell cycle from G2 into mitosis. The
evidence is as follows. The C-terminal domain of
poly(A) polymerase contains several consensus sites
for the kinase as well as ‘non-consensus’ sites that
di¡er from the consensus sites in a single amino acid.
MPF can phosphorylate the polymerase in vivo and
in vitro, full phosphorylation is dependent on the
aforementioned sites, and the polymerase is most
strongly phosphorylated in vivo at the time when
MPF activity is at its peak [84,85]. Poly(A) polymer-
ase activity is inhibited by phosphorylation. The ef-
fect is moderate when the steady-state population of
di¡erent phosphorylated forms is compared to the
unphosphorylated enzyme [69], but quite dramatic
when the most highly phosphorylated form is as-
sayed [84]. Both speci¢c (AAUAAA- and CPSF-
dependent) and non-speci¢c (Mn2-dependent) activ-
ities are reduced. Thus, phosphorylation must a¡ect
either the active center or the interaction with the
RNA primer. Phosphatase treatment activates the
enzyme [84]. It is thought that the inhibition of poly-
adenylation contributes to a general downregulation
of gene expression during mitosis.
The poly(A) polymerase is also the target in an
unrelated regulatory mechanism: the U1A protein
is a component of the U1 snRNP which recognizes
5P-splice sites. A speci¢c sequence of seven nucleo-
tides in a stem-loop structure of the U1 snRNA is
required for binding of U1A. Two molecules of U1A
protein also bind two conserved stem-loop structures
containing the essential heptanucleotide in its own
mRNA and autoregulates its expression through in-
hibition of 3P-processing [86]. U1A protein inhibits
the polyadenylation of a substrate RNA containing
the two binding sites even in the non-speci¢c, Mn2-
dependent polyadenylation reaction in which no 3P-
processing factor except poly(A) polymerase is in-
volved. U1A protein also binds to immobilized
poly(A) polymerase, but only in the presence of an
RNA containing two U1A binding sites.
The U1A protein binds to the RNA by means of
its N-terminal RNP domain plus a few £anking ami-
no acid residues [87,88]. The interaction with poly(A)
polymerase is mediated by approximately a dozen
amino acids directly adjacent to the RNA binding
domain [89]. While a monomeric synthetic pep-
tide containing these amino acids has no e¡ect on
poly(A) polymerase activity, the enzyme is strongly
inhibited when the peptide is conjugated to a carrier
protein at high density. Thus, the only function of
the RNA with its two U1A binding sites is to e¡ect a
dimerization of the bound proteins.
Poly(A) polymerase is sensitive to U1A due to an
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amino acid sequence at its extreme C-terminus: fu-
sion of the last 20 amino acids of mammalian poly-
(A) polymerase confers U1A sensitivity to yeast
poly(A) polymerase, which is normally insensitive,
and an inert carrier protein to which this amino
acid sequence has been attached binds RNA-U1A
complexes [89]. Although a U1A dimer is required
for binding and inhibiting poly(A) polymerase, the
enzyme contains only one copy of the interacting C-
terminal amino acid sequence, which also does not
have any obvious repeat structure. Thus, it is likely
that the two U1A proteins interact in such a way
that they present a single surface for recognition by
poly(A) polymerase. As in the case of the C-terminal
phosphorylation of poly(A) polymerase, it will be
interesting to determine how the U1A interaction
at the non-essential C-terminus is transmitted to
the catalytic core of the enzyme.
The signi¢cance of the regulatory mechanism just
described goes beyond the regulation of U1 snRNP
production because it a¡ords insights into other reg-
ulatory phenomena and possibly also into the more
general problem of the connection between splicing
and cleavage/polyadenylation. Several genes have
been described in which splice sites or sequences re-
sembling them regulate cleavage and polyadenyla-
tion. In one case, found in papillomaviruses, an iso-
lated 5P-splice site inhibits 3P-processing at a
downstream cleavage/polyadenylation site [90]. The
e¡ect has been reconstituted in a simple, highly pu-
ri¢ed in vitro system: puri¢ed U1 snRNP inhibits
the polyadenylation of a substrate RNA containing
an upstream 5P-splice site. As with U1A autoregula-
tion, inhibition is seen even in the non-speci¢c,
Mn2-dependent reaction which contains no protein
except recombinant poly(A) polymerase and the in-
hibitory snRNP [91]. However, the inhibitor in this
case is not the U1A protein, presumably because it is
present in the U1 snRNP as a monomer. Instead, the
U1 70 K protein is the active ingredient. This protein
contains four di¡erent motifs resembling the U1A
amino acid sequence responsible for inhibition of
poly(A) polymerase. Simultaneous alanine replace-
ments in all four motifs abolished the inhibitory ef-
fect on polyadenylation [91].
3P-Processing is believed to be coupled to the splic-
ing of 3P-terminal introns. Coupling has been postu-
lated on theoretical grounds in the context of the
‘exon de¢nition model’ [92], but can also be observed
experimentally: in vitro and in vivo, splicing and
cleavage/polyadenylation occurring on the same
RNA molecule stimulate each other [93,94]. This
stimulation is disrupted by the U1A peptide-BSA
conjugate mentioned above [89]. It remains to be
determined which interaction exactly is sensitive to
the peptide and how this stimulatory e¡ect of splic-
ing can be reconciled with the inhibitory e¡ect in the
case discussed above and in others.
The best-studied example of alternative polyaden-
ylation is the synthesis of IgM heavy chains. Alter-
native polyadenylation is associated with alternative
splicing: the upstream poly(A) site (Ws site) is located
in an intron. Cleavage and polyadenylation at this
site remove two downstream exons and lead to the
synthesis of secreted IgM. If this poly(A) site is not
used, it is removed by splicing of the intron so that
two additional exons are included in the mature
mRNA, a poly(A) site (the Wm site) further down-
stream is used, and the membrane-bound form of the
antibody is generated.
The preference for one or the other type of RNA
processing is regulated during B cell di¡erentiation:
early stages use the downstream Wm poly(A) site and
produce mostly membrane-bound IgM, whereas fully
di¡erentiated cells use the upstream Ws poly(A) site
and generate secreted antibodies. Two types of ex-
periments strongly suggested that the poly(A) site
switch does not require any gene-speci¢c factor. In
one experiment it was shown that the switch oper-
ated only when the two poly(A) sites competed in the
same pre-mRNA but not when they were located in
di¡erent transcription units [95,96]. In the second
type, a gene was built that contained a similar ar-
rangement of alternative splice and poly(A) sites as
the IgM heavy chain gene, but was composed of
di¡erent sequences. Provided that the strengths of
the poly(A) sites were matched, this pre-mRNA
showed the same poly(A) site switch during B cell
development as the authentic gene [97]. The interpre-
tation of these experiments, supported by additional
evidence [98], was that pre-B cells are ine⁄cient in
cleavage/polyadenylation and thus prefer the stron-
ger Wm site. Di¡erentiation to plasma cells entails an
increase in 3P-processing e⁄ciency; thus, the weaker
Ws site is used due to its upstream location.
CstF was suggested to be the factor limiting in
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pre-B cells and upregulated during di¡erentiation
[99], and this suggestion is strongly supported by
recent experiments [100]. Western blots showed that
CstF-64 is expressed at least 10-fold more strongly
upon induction of B-cell di¡erentiation, whereas
CstF-77 is not upregulated. Increased synthesis of
CstF-64 leads to a higher abundance of heterotrimer-
ic CstF. Arti¢cial overexpression of CstF-64 in a
cell line was su⁄cient to induce a preferential use
of the Ws site. As predicted by the model, the Wm
site was found to bind CstF more e⁄ciently than
the Ws site.
3. Cleavage and polyadenylation in S. cerevisiae
3.1. Cleavage and polyadenylation signals
Analysis of 3P-end formation signals in S. cerevi-
siae has been much more complicated than in mam-
malian cells because no highly conserved sequence
motif equivalent to AAUAAA was apparent in se-
quence comparisons. In their degeneracy, the yeast
signals are comparable to the upstream and down-
stream elements of mammalian poly(A) sites. Never-
theless, a large number of mutagenesis studies have
¢nally led to the consensus that a cleavage and poly-
adenylation signal in S. cerevisiae is composed of
three blocks of sequences: the nucleotides at the
poly(A) addition site itself, a ‘positioning element’
upstream of this site and an ‘e⁄ciency element’ still
further upstream [101^103].
The positioning element resembles the mammalian
AAUAAA sequence in at least two respects :
AAUAAA is one of several related sequences that
function as positioning elements, and the sequence
leads to pre-mRNA cleavage approximately 20 nu-
cleotides downstream. Cleavage occurs preferentially
at PyAn sequences. It is unknown and cannot be
deduced from a comparison of genomic sequences
and cDNAs which phosphodiester bond exactly is
cleaved, but in analogy with the mammalian system,
it is likely to be on the 3P-side of an A residue.
Cleavage is enhanced by the e⁄ciency element,
which is optimally located 10^20 nucleotides up-
stream of the positioning element, but can also func-
tion further upstream. E⁄ciency elements are also
variable, but are related to the sequence UAUAUA.
The somewhat unexpected summary of all this is that
the polyadenylation signals in yeast may not be so
di¡erent from the mammalian sequences after all :
the sequences at the cleavage sites are similar, the
mammalian AAUAAA sequence appears to corre-
spond to the positioning element, and the mamma-
lian upstream elements might correspond to the
yeast e⁄ciency elements [103]. The major di¡erence
between the two types of signals is the apparent ab-
sence of a downstream element in S. cerevisiae. In
Schizosaccharomyces pombe, however, a downstream
element has been identi¢ed [104]. One should also
keep in mind that the elements of the mammalian
polyadenylation signals are de¢ned not just by their
nucleotide sequences and their positions with respect
to the cleavage site, but also by the proteins which
bind them. Although, as described in the following
section, a number of the polypeptides involved in
cleavage and polyadenylation in yeast have mamma-
lian counterparts, including those responsible for se-
quence-speci¢c RNA binding, the way in which the
yeast substrate RNA is recognized is essentially un-
known.
3.2. Cleavage and polyadenylation factors
An in vitro system for 3P-end processing derived
from S. cerevisiae has been available for some time
[105] and has been essential for the puri¢cation of
processing factors. As one would expect from an
experimental system like yeast, genetic screens have
also made major contributions. Perhaps more impor-
tantly, genetic experiments provide a stringent assay
for testing the biological relevance of at least some of
the observations made in vitro.
The nomenclature of yeast 3P-processing factors is
based on an initial fractionation of crude extracts by
ion exchange chromatography [106] : cleavage factors
I and II (CF Iy and IIy ; note that these proteins are
not related to the mammalian factors bearing the
same names) are necessary and su⁄cient to reconsti-
tute cleavage. CF Iy, polyadenylation factor I (PF I)
and poly(A) polymerase catalyze polyadenylation of
a pre-cleaved RNA. This scheme has recently led to
some confusion and debate, because the association
and co-puri¢cation of components of these factors
turned out to be variable to some extent. While it
seems likely that the inventory of polypeptides is
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now complete, variable associations have made it
di⁄cult to assign functions to them.
The ¢rst 3P-processing factor from yeast to be pu-
ri¢ed and cloned was poly(A) polymerase [107,108].
The protein is encoded by an essential gene, PAP1.
Pap1p is 47% identical with the mammalian enzyme
over its 400 N-terminal amino acids, and the cata-
lytic properties are also similar. In particular, like the
mammalian polymerase, the yeast enzyme does not
discriminate between di¡erent RNA substrates. As a
striking example of the variability of association,
poly(A) polymerase was initially puri¢ed as an iso-
lated polypeptide and included as such in the scheme
outlined above. However, more recently, the enzyme
has been identi¢ed as a subunit of a more complex
assembly, PF I (see below).
Upon puri¢cation, CF Iy was separated into CF
IA and CF IB. The former consists of four polypep-
tides [109,110]. Two subunits of 76 and 38 kDa are
the products of the RNA14 and RNA15 genes, re-
spectively, which had been previously identi¢ed in a
genetic screen and shown to be components of the
3P-processing machinery by biochemical experiments
[111]. The Rna15 protein contains an RNP domain
and binds RNA in vitro. The Rna14 and Rna15
proteins have limited sequence similarity to the 77-
kDa and 64-kDa subunits, respectively, of mamma-
lian CstF (see Section 2.2). A third CF Iy subunit of
70 kDa is the product of the PCF11 gene, also iden-
ti¢ed in a genetic screen [112]. Rna14, Rna15 and
Pcf11 exemplify what has been found for all poly-
peptides involved in 3P-end processing that have been
analyzed so far: the genes encoding the proteins are
essential, the phenotypes of conditional-lethal muta-
tions con¢rm their involvement in 3P-end formation
in vivo, and extracts made from these mutants re-
capitulate the phenotype in vitro. A fourth CF Iy
subunit of 50 kDa has been termed Clp1 [110].
Mammalian sequences homologous to Clp1 have
been found in the data base [12], but they do not
correspond to any of the known components of the
mammalian cleavage and polyadenylation factors.
An additional polypeptide found associated with
CF IA is the poly(A) binding protein of yeast, en-
coded by the PAB1 gene. This protein, not to be
confused with mammalian PABP2 (see Section 2.2),
has four RNP domains and binds speci¢cally to
poly(A). It covers the poly(A) tails of mRNAs in
the cytoplasm and mediates the poly(A) tail’s e¡ects
in translation and probably mRNA decay (see Intro-
duction). The signi¢cance of its association with
CF Iy will be discussed below (see Section 3.3).
Although mammals have a poly(A) binding protein
very similar to yeast Pab1p in structure and probably
at least partially equivalent in its cytoplasmic func-
tion, the mammalian protein is not known to be
involved in polyadenylation.
CF IB is a single polypeptide of 73 kDa, the prod-
uct of the HRP1 or NAB4 gene [113]. Initial experi-
ments suggested that Hrp1p/Nab4p, like CF IA, was
required both for cleavage and for polyadenylation.
More recently, however, it has been demonstrated
that Hrp1p/Nab4p is not required for cleavage per
se, but for the selection of the correct cleavage site:
in the absence of the protein, several cleavage sites
upstream of the correct one were used [114].
Although an e¡ect on polyadenylation was found
in reconstitution experiments in vitro, no polyadenyl-
ation defect was seen in vivo [114]. Genetic experi-
ments showed direct interactions of Hrp1/Nab4 with
subunits of CF IA. The protein contains two RNP
domains and can be UV cross-linked to cleavage/
polyadenylation substrates. Hrp1p/Nab4p is a shut-
tling protein, i.e. it is exported from the nucleus into
the cytoplasm and transported back. This is interest-
ing in connection with the observation that polyad-
enylation is essential for mRNA export. Whether
Hrp1p/Nab4p has indeed a direct role in the trans-
port of mRNA remains to be elucidated. It is also
interesting that Hrp1p/Nab4p has features of an
hnRNP protein. None of the numerous mammalian
hnRNP proteins has been shown to be involved in
mRNA 3P-end formation so far.
CF IIy has been puri¢ed as a heterotetramer [115].
The largest subunit (150 kDa) is the product of the
CFT1 [116] or YHH1 [117] gene and homologous to
the largest subunit of mammalian CPSF. The 105-
kDa subunit, encoded by the CFT2 [115] or YDH1
[117] gene, is homologous to the 100-kDa subunit of
CPSF. This protein could be UV cross-linked to
RNA in an ATP-dependent manner in the context
of the tetramer [115]. The 100-kDa subunit, product
of the BRR5 [118] or YSH1 [37] gene, is related to
CPSF-73. A fourth polypeptide of 90 kDa was not
identi¢ed.
PF I has been puri¢ed as an assembly of at least
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nine polypeptides [117]. Surprisingly, three of them
correspond to the three genetically assigned subunits
of CF IIy just described and, thus, the three largest
subunits of CPSF. A small PF I subunit of 26 kDa,
encoded by the YTH1 gene, is homologous to the
30-kDa subunit of CPSF [27]. The apparent absence
of Yth1p in the CF IIy preparation just discussed
may well have been due to a sensitivity problem:
the protein was detectable in PF I only by antibody
reactivity, not by silver staining [117], and CF IIy
was not tested with this antibody. Poly(A) polymer-
ase is also associated with PF I as shown by identi-
¢cation of the polypeptide in the preparation and by
poly(A) polymerase activity of puri¢ed PF I. A sub-
unit of 85 kDa is the product of the PTA1 gene.
Although a mutation in this gene, pta1-1, was ini-
tially found because it accumulates unspliced tRNA
precursors, splicing endonuclease activity in extracts
is normal [119]. Extracts do, however, have a defect
in polyadenylation whereas cleavage of pre-mRNA
is normal [117]. A subunit of 55 kDa is encoded by a
gene, FIP1, that was ¢rst identi¢ed in a two-hybrid
screen with poly(A) polymerase as the bait [120].
Fip1p by itself binds tightly to poly(A) polymerase
[120], but, surprisingly, it inhibits the enzyme [71]
while the complete PF I assembly stimulates (see
Section 3.3). Two additional subunits of PF I of 58
and 53 kDa are encoded by genes named PFS1 and
PFS2, respectively (P. Preker, unpublished data cited
in [12]).
The 3P-processing factors of S. cerevisiae and their
relationships to the mammalian proteins are sum-
marized in Table 2.
With respect to the list of processing factors, the
published data leave open two related questions. The
¢rst concerns the identity of CF IIy. It seems likely
that the CF IIy described by Moore and colleagues
[115] is completely contained in the PF I preparation
of Preker et al. [117]. This makes the untested pre-
diction that PF I together with CF IA and CF IB
should su⁄ce for the entire 3P-processing reaction,
cleavage and polyadenylation. However, it is also
possible that the CPSF homologues form a core
complex that associates variably with additional poly-
peptides, resulting in CF IIy or PF I. The second
question concerns the polypeptides’ roles in cleavage
and polyadenylation. Since the CF/PF classi¢cation
implies functions in one or the other of the two par-
tial reactions, the assignment of subunits to the three
factors is not merely a question of nomenclature.
Both questions have not been resolved for the simple
reason that so far the factors puri¢ed to homogene-
ity have only been assayed in crude systems, either
by complementation of extracts prepared from mu-
tant strains or in reconstitution assays in which at
least one of the other components was not pure.
Help in assigning functions to polypeptides comes
from the study of mutant extracts. However, care
must be taken in the interpretation of these data.
While mutations would be expected to be speci¢c
for single polypeptides, the genetic inactivation of
one subunit may destabilize other components of a
complex. Alternatively, an add-back experiment with
an isolated polypeptide may be impossible because
complex assembly can be so tight that the wild-type
Table 2
Cleavage and polyadenylation factors in yeast
Factor Subunit
(kDa)
Gene Mammalian
homologuea
CF IAb 76 RNA14 CstF-77
72 PCF11 -
50 CLP1 ^
38 RNA15 CstF-64
CF IB 73 HRP1 ^
CF IIcy 150 YHH1/CFT1 CPSF-160
105 YDH1 CPSF-100
100 YSH1/BRR5 CPSF-73
90 unknown ^
PF Ic 150 YHH1/CFT1 CPSF-160
105 YDH1 CPSF-100
100 YSH1/BRR5 CPS-73
85 PTA1 ^
64 PAP1 poly(A) polymerase
58 PFS1 ^
55 FIP1 ^
53 PFS2 ^
26 YTH1 CPSF-30
Reproduced from an article entitled ‘mRNA formation: 3P end’,
Encyclopedia of Life Sciences, Macmillan Reference Ltd/Grove’s
Dictionaries Inc. (forthcoming).
aMammalian homologues have been listed only as far as they are
known 3P-processing factors. For some other subunits of the
yeast factors, homologous mammalian sequences have been
found in the data base, but it is unknown whether the polypep-
tides play a role in 3P-processing.
bSince PAB I is not a stoichiometric subunit of CF Iy it is not
listed here.
cAt least three subunits of CF II are also present in PF I. There-
fore, it is possible that PF I actually contains all of CF II.
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polypeptide is not incorporated into the complex to
replace the defective one (e.g. [117]). In addition, a
point mutation may speci¢cally a¡ect only one of
several functions of a protein.
The data currently available can be summarized as
follows.
Point mutations in genes encoding three subunits
of CF IA, RNA14, RNA15 and PCF11, lead to de-
fects in both cleavage and polyadenylation in ex-
tracts [111,112]. This is in agreement with a require-
ment of CF IA for both reactions in reconstitution
experiments. However, complementation of extracts
by single polypeptides has not been achieved, so it
remains to be determined if indeed each individual
subunit plays a role in both reactions.
For the yeast homologues of the two largest CPSF
subunits, CFT1/YHH1 and CFT2/YDH1, no condi-
tional mutants are available. The situation is not
entirely clear for BRR5/YSH1. Extracts made after
genetic inactivation by two di¡erent means, includ-
ing depletion of the polypeptide by transcriptional
shut-o¡, had a clear polyadenylation defect, but
cleavage was normal, suggesting that the Brr5/Ysh1
polypeptide is speci¢cally required for polyadenyla-
tion [37,118]. However, a cold-sensitive brr5 mutant
appears to have a cleavage defect under restrictive
conditions in vivo [118]. Thus, for the three identi¢ed
subunits of CF IIy, genetic evidence is incomplete.
As far as it is available, it supports a role in poly-
adenylation, whereas a role in cleavage is uncertain.
For the smallest CPSF homologue, Yth1p, identi-
¢ed as a PF I subunit, in vitro assays with extracts
from a point mutant showed a speci¢c defect in poly-
adenylation, not cleavage [27]. The same is true for
poly(A) polymerase: pap1 mutants have defects in
polyadenylation in vivo and in vitro, but cleavage
is normal [111,121,122]. Similar experiments con¢rm
that two other subunits of PF I, Pta1p and Fip1p are
speci¢cally involved in polyadenylation [117,120].
The available genetic information on PF I subunits
is thus in good agreement with the biochemical as-
says, which show a requirement for PF I in poly-
adenylation but not in cleavage. No mutants are
available for the other PF I subunits.
While the genetic data summarized above gener-
ally provide satisfying support for the biochemical
experiments, reconstitution assays predict that there
should be at least one polypeptide speci¢cally re-
quired for cleavage. This should of course be a sub-
unit of CF IIy (or of PF I if this contains all of CF
IIy). This polypeptide remains to be identi¢ed and its
role con¢rmed by the analysis of a mutant.
Obviously, there is a signi¢cant degree of conser-
vation between the cleavage and polyadenylation
factors of mammals and yeast [12]. Nevertheless,
there are polypeptides in mammals for which no ho-
mologues have been found in the yeast genome
(CstF-50, both subunits of CF Im). Likewise, several
subunits of PF I have no known homologues in
mammals. Other yeast polyadenylation factors
(Clp1p, Pab1p) do have homologues (even well
studied in the case of Pab1p), but they are not
(yet) known to be involved in 3P-end formation of
mRNA.
As discussed previously [12,27], the functions of
sequence-related components of the 3P-end process-
ing machineries of yeast and mammals do not ap-
pear to correspond: mammalian CstF is involved in
cleavage, not polyadenylation, but the yeast counter-
parts of CstF subunits, RNA14 and RNA15, appear
to be necessary for both reactions. Mammalian
CPSF is involved in both reactions. Although the
biochemical data for the yeast homologues are un-
clear, as these polypeptides have been found both in
CF II and PF I, genetic data so far provide clear
support only for a role in polyadenylation. While
this apparent shift in function may seem unusual,
one has to keep in mind that there are only two
known catalytic functions involved in 3P-end forma-
tion, those of the anonymous endonuclease and of
poly(A) polymerase. All other polypeptides have no
known function but to build up the processing com-
plex through a network of cooperative interactions.
It is not so di⁄cult to imagine that these interactions
could change during the course of evolution.
3.3. Reaction mechanism
Like the mammalian reaction, cleavage in the
yeast system is resistant to EDTA [106]. ATP stim-
ulates cleavage, but other ribonucleoside triphos-
phates substitute [105,106]. The reaction also pro-
ceeds with low e⁄ciency in the absence of added
ATP [106]. Coupling between cleavage and polyad-
enylation is less tight than in the mammalian system:
cleaved RNA lacking a poly(A) tail is readily detect-
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able in an in vitro reaction even when no e¡ort is
made to block polyadenylation, and poly(A) polym-
erase is dispensable for cleavage (see Section 3.2).
Little is known about the way in which the factors
described above bind their substrate RNA. Even the
existence of a stable processing complex has not been
demonstrated. Several polypeptides in the yeast
cleavage and polyadenylation machinery are known
to bind RNA (see Section 3.2), but the binding sites
are mostly unknown. UV cross-linking of puri¢ed
recombinant Hrp1p to RNA was dependent on the
presence of the e⁄ciency element (see Section 3.1).
Hrp1p was thus suggested to be responsible for rec-
ognizing this sequence [113] (but see [114]).
As described above, puri¢ed PF I contains, in ad-
dition to poly(A) polymerase, at least eight polypep-
tides, including the homologues of the mammalian
factor tethering poly(A) polymerase to AAUAAA-
containing RNAs. The ‘poly(A) polymerase holoen-
zyme’ from yeast ( = PF I) has much higher polymer-
ase activity on a molar basis than the isolated Pap1p,
possibly through an increased processivity. However,
it appears that CF Iy is still required for proper
substrate recognition [117], although stringent specif-
icity assays for this complex have not been pub-
lished.
As mentioned above, puri¢ed CF Iy contains some
poly(A) binding protein 1 (Pab1p) [110]. Interactions
between this protein and subunits of CF Iy were also
detected genetically [123]. Extracts made from pab1
mutants have normal cleavage activity, and they also
polyadenylate the upstream cleavage product. How-
ever, the poly(A) tails are approximately 40 nucleo-
tides too long [110,123]. Addition of puri¢ed Pab1p
restores normal length control to the extracts. Pab1p
acts by activating the poly(A) nuclease (PAN)
[124,125], which balances an excessive growth of
poly(A) tails by trimming from the 3P-end [126].
Pab1p is also an inhibitor of poly(A) polymerase
[107], and this might contribute to its e¡ect on poly-
(A) tail length. In agreement with the biochemical
data, both pab1 and pan mutants have elongated
poly(A) tails in vivo [126,127]. An additional protein,
Pbp1p, a¡ects poly(A) tail length in vitro, presum-
ably through an iteration with Pab1p [128]. In vivo,
pbp1 mutants have normal poly(A) tail lengths.
The mechanism of length control in S. cerevisiae
appears to di¡er from the one described above for
the mammalian system (see Section 2.3): a di¡erent
protein is involved (Pab1p in yeast versus PABP2 in
mammalian cells), and the absence of the protein has
opposite e¡ects: poly(A) tail synthesis in the absence
of PABP2 is ine⁄cient, whereas the tails in the ab-
sence of Pab1p rapidly grow to an excessive length
due to the lack of exonucleolytic shortening. Note
however, that even in the absence of Pab1p or Pan
the tails are of a relatively uniform length and only
40 nucleotides too long. Thus, an additional mecha-
nism is likely involved in length control in yeast,
which might be similar to the one in the mammalian
system. The yeast genome contains an open reading
frame with some sequence similarity to mammalian
PABP2. The similarity is limited to the RNP-type
RBD. Disruption of this open reading frame re-
vealed that the gene is not essential, and the deletion
strain has no polyadenylation defect (M. Sadowski,
U. Ku«hn, L. Minvielle-Sebastia and E. Wahle, un-
published data).
4. The relationship between 3P-end processing and
transcription
Although 3P-end cleavage and polyadenylation can
be studied as isolated phenomena in vitro, two types
of evidence suggested several years ago that in vivo
3P-end formation is coupled to transcription. In one
type of experiment, cleavage and polyadenylation
were shown to be defective in vivo when the pre-
mRNA was synthesized not by RNA polymerase II
but by RNA polymerase I or III. In the second,
transcription termination was shown to depend on
proper 3P-end formation: mutational inactivation of
the cleavage/polyadenylation signals also abolished
termination (discussed in [5,6]). A biochemical basis
for the connection between transcription and cleav-
age/polyadenylation is now beginning to emerge.
Coupling of 3P-processing to transcription is two-
fold, with one indirect and one direct connection.
The indirect connection is made by the 5P-modi¢ca-
tion distinguishing all mRNAs or mRNA precursors
from almost all other RNAs, the m7G(5P)ppp(5P)G
cap. Although the cap is not strictly required for 3P-
end formation, it is strongly stimulatory [129,130].
The e¡ect seems to be mediated by an interaction
between the nuclear heterodimeric cap binding com-
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plex (reviewed by [131]) and an as yet unidenti¢ed
component of the 3P-processing complex [132]. The
cap has been known for a long time to be added co-
transcriptionally. After the vaccinia virus-encoded
capping enzyme had ¢rst been found to associate
with the viral RNA polymerase [133], capping en-
zymes from both yeast and mammalian cells have
now been shown to bind the carboxy-terminal do-
main (CTD) of RNA polymerase II [134^136]. The
CTD consists of a species-speci¢c number of repeats
of a heptapeptide. Binding of capping enzymes de-
pends on phosphorylation of the repeat upon tran-
scription initiation. Since the CTD is speci¢c for
RNA polymerase II, the association can account
for the observed speci¢city of capping for RNA po-
lymerase II transcripts, and the dependence of 3P-
processing on capping e¡ects its indirect dependence
on RNA polymerase II transcription.
However, there is also a direct link between the
polymerase and 3P-processing, and again it involves
the CTD. When transcription in vivo is catalyzed by
an RNA polymerase II from which most of the CTD
has been deleted, cleavage and polyadenylation of
the resulting RNA are impaired [137]. Although a
failure to cap the RNA can account for some of
the polyadenylation defect, even the proportion of
RNA that does receive a cap is processed poorly
[134]. This has been traced to an interaction between
two cleavage/polyadenylation factors, CPSF and
CstF, with the CTD [137]. Binding is independent
of CTD phosphorylation in this case. More recently,
it was reported that CPSF also binds subunits of the
general transcription factor TFIID [138]. TFIID is
part of the pre-initiation complex of RNA polymer-
ase II. After the start of transcription, the associa-
tion was no longer detectable, and CPSF was found
to be associated with the RNA polymerase, presum-
ably the CTD. It was thus suggested that at least
some of the cleavage and polyadenylation factors
are brought into the preinitiation complex of RNA
polymerase II through an interaction with TFIID,
handed over to the elongating polymerase after the
start of transcription and then bind the nascent
RNA once a proper binding site has been generated.
These data provide an additional plausible explan-
ation for the dependence of 3P-end formation on
RNA polymerase II transcription. They do not ex-
plain the dependence of transcription termination on
cleavage/polyadenylation, but they suggest that the
elongating transcription complex undergoes a rear-
rangement by transfer of CPSF and possibly other
factors to the RNA after the polyadenylation signal
has been passed. It is conceivable that this change in
the complex plays a role in causing the polymerase
to terminate downstream of the poly(A) site. How-
ever, there is reason to believe that a change in the
transcription complex by transfer of proteins is not
su⁄cient to cause termination: In a survey of di¡er-
ent yeast mutants de¢cient in 3P-processing, all mu-
tations a¡ecting cleavage had a termination defect
whereas all mutants with a defect in polyadenylation
had normal termination. From these and other data
it was concluded that cleavage of the pre-mRNA
may be essential to cause transcription termination
[139].
It has been reported that in a crude nuclear ex-
tract, cleavage and polyadenylation of pre-mRNA
generated in situ by RNA polymerase II is much
more e⁄cient than processing of exogenous RNA
[140]. Similar experiments in which a reconstituted
RNA polymerase II transcription system has been
combined with a reconstituted cleavage/polyadenyla-
tion system have not yet been reported. However,
recent results suggest that RNA polymerase II may
have a role in 3P-end cleavage beyond delivering the
proteins which carry out the job. In a reconstituted
system that cleaved pre-made RNA precursors, in-
dependently of transcription, RNA polymerase II,
and in particular its C-terminal domain, behaved
like a cleavage factor [141]. Its depletion from nu-
clear extracts inhibited 3P-processing, and the e⁄-
ciency of the reaction could be restored by the addi-
tion of puri¢ed enzyme. Although these experiments
were prompted by the search for a phosphorylated
protein that might replace creatine phosphate in the
assay (see Section 2.3), phosphorylation of the CTD
was not essential. Under some conditions, the phos-
phorylated form was more e⁄cient, though. The ex-
act role of RNA polymerase II and its CTD remains
to be investigated.
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